Clinical Trial: Verification of the usefulness of a filtration membrane (Soft Micro Pore Filter (S-MPF) for separating novel rare cells in peripheral blood circulation tumor cell extraction (Japan)

Tokyo, July 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058385) titled 'Verification of the usefulness of a filtration membrane (Soft Micro Pore Filter (S-MPF) for separating novel rare cells in peripheral blood circulation tumor cell extraction' on July 7.

Study Type: Observational

Primary Sponsor: Institute - kawanishi City Medical Center

Condition: Condition - The usefulness of a filtration membrane (Soft Micro Pore Filter (S-MPF) for isolating novel rare cells in peripheral blood circulation tumor cell extraction is examined. Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - The usefulness of a filtration membrane (Soft Micro Pore Filter (S-MPF) for isolating novel rare cells in peripheral blood circulation tumor cell extraction is examined. Basic objectives2 - Efficacy

Eligibility: Age-lower limit - 20 years-old = Gender - Male and Female Key inclusion criteria - 1) The patient has been diagnosed with a malignant tumor with a strong probability of clinical diagnosis. 2) The age of registration must be at least 20 years old and not more than 100 years old. 3) ECOG performance status is 0 or 1. 4) The test result must be completed within 30 days prior to the date of registration, and all of the following must be satisfied. WBC>3,000/mm3, 9.0g/dl Platelet count> 10x104 /mm3 AST<100IU/L, ALT<100IU/L Total bilirubin< 1.5mg/dL Serum creatinine< 2.0mg/dL 5) Cases in which the patient's consent to participate in this study has been obtained in writing Key exclusion criteria - 1) Have an infectious disease that requires systemic treatment, including HIV, HBV, or HCV infection. 2) Have a fever of 38 centi-degrees or higher in axillary temperature within 24 hours prior to enrollment without the use of antipyretics. 3) Cases judged by the attending physician to be inappropriate for conducting this study Target Size - 100

Recruitment Status: Recruitment status - Suspended Date of protocol fixation - 2024 Year 05 Month 07 Day Date of IRB - 2024 Year 05 Month 02 Day Anticipated trial start date - 2024 Year 05 Month 07 Day Last follow-up date - 2035 Year 12 Month 29 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066751

Disclaimer: Curated by HT Syndication.